• Lupus Anticoagulants
  • Histoplasma capsulatum Antigen, CSF
  • Congenital malformation
  • Diabetic neuropathy
  • Synovial Fluid Analysis
  • Carbamazepine, Total, Serum
  • 5-Hydroxytryptamine Receptor 2C (HTR2C)
  • Beta Thalassemia Genetic Testing
  • Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
  • Treponema pallidum Antibody by TP-PA, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue
Medical Test

CPT
Access to MLH1 Hypermethylation (Promoter Methylation) Analysis, Tissue is restricted.